These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 25784290

  • 21. Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
    Diao ZB, Sun TX, Zong Y, Lin BC, Xia YS.
    J Int Med Res; 2020 Dec; 48(12):300060520967818. PubMed ID: 33284712
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Identification of potential micro-messenger RNAs (miRNA-mRNA) interaction network of osteosarcoma.
    Xu K, Zhang P, Zhang J, Quan H, Wang J, Liang Y.
    Bioengineered; 2021 Dec; 12(1):3275-3293. PubMed ID: 34252359
    [Abstract] [Full Text] [Related]

  • 29. Increased expression of microRNA-26a-5p predicted a poor survival outcome in osteosarcoma patients: An observational study.
    Xie XY, Chen XM, Shi L, Liu JW.
    Medicine (Baltimore); 2021 Mar 26; 100(12):e24765. PubMed ID: 33761638
    [Abstract] [Full Text] [Related]

  • 30. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C, Wu K, Wang S, Wei G.
    J Cell Biochem; 2018 Jul 26; 119(7):5646-5656. PubMed ID: 29384226
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.
    Lung Cancer; 2013 Sep 26; 81(3):388-396. PubMed ID: 23756108
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Detection of Plasma MicroRNA Signature in Osteosarcoma Patients.
    Allen-Rhoades W, Yustein JT.
    Methods Mol Biol; 2018 Sep 26; 1699():113-118. PubMed ID: 29086373
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The diagnostic effect of serum miR-139-5p as an indicator in osteosarcoma.
    Zhou L, Ma X, Yue J, Chen T, Wang XY, Wang ZW, Pan J, Lin Y.
    Cancer Biomark; 2018 Sep 26; 23(4):561-567. PubMed ID: 30347602
    [Abstract] [Full Text] [Related]

  • 38. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
    Wang SN, Luo S, Liu C, Piao Z, Gou W, Wang Y, Guan W, Li Q, Zou H, Yang ZZ, Wang D, Wang Y, Xu M, Jin H, Xu CX.
    Mol Ther; 2017 Sep 06; 25(9):2140-2149. PubMed ID: 28648665
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. MicroRNAs for osteosarcoma in the mouse: a meta-analysis.
    Chang J, Yao M, Li Y, Zhao D, Hu S, Cui X, Liu G, Shi Q, Wang Y, Yang Y.
    Oncotarget; 2016 Dec 20; 7(51):85650-85674. PubMed ID: 27852052
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.